论文部分内容阅读
目的探讨米非司酮治疗绝经过渡期功能失调性子宫出血(功血)的临床疗效。方法选取2011年1月—2014年1月宁夏固原市原州区人民医院收治的绝经过渡期功血患者280例,随机分为试验组与对照组,各140例。对照组患者予以妇康片治疗,试验组患者予以米非司酮治疗。观察两组患者临床疗效、止血时间及不良反应发生情况。结果试验组患者总有效率高于对照组,止血时间短于对照组,不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论米非司酮治疗绝经过渡期功血的临床疗效显著,可缩短患者的止血时间,且不良反应少,安全性高。
Objective To investigate the clinical efficacy of mifepristone in the treatment of dysfunctional uterine bleeding (dysfunctional uterine bleeding) during menopause. Methods 280 cases of menopausal transitional dysfunctional uterine bleeding admitted to Yuanzhou District People’s Hospital of Guyuan, Ningxia from January 2011 to January 2014 were randomly divided into experimental group and control group, with 140 cases each. Patients in the control group were treated with Fukang Tablet and patients in the test group were treated with mifepristone. Clinical efficacy, hemostasis time and adverse reactions in both groups were observed. Results The total effective rate of patients in experimental group was higher than that of control group, the bleeding time was shorter than that of control group, and the incidence of adverse reactions was lower than that of control group. The difference was statistically significant (P <0.05). Conclusion The efficacy of mifepristone in the treatment of menopausal transitional dysfunction is significant, which can shorten the bleeding time of patients with less adverse reactions and high safety.